Skip to main content

Compare Stocks

Date Range: 

 HaemoneticsInspire Medical SystemsIntegra LifeSciencesInari MedicalTandem Diabetes Care
SymbolNYSE:HAENYSE:INSPNASDAQ:IARTNASDAQ:NARINASDAQ:TNDM
Price Information
Current Price$52.00$166.80$70.97$81.97$76.81
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score2.11.21.41.51.6
Analysis Score4.31.31.24.43.4
Community Score2.22.42.23.32.5
Dividend Score0.00.00.00.00.0
Ownership Score1.71.71.70.01.7
Earnings & Valuation Score2.50.61.90.00.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$115.40$177.70$70.90$117.17$121.17
% Upside from Price Target121.92% upside6.53% upside-0.10% downside42.94% upside57.75% upside
Trade Information
Market Cap$3.04 billion$4.65 billion$5.91 billion$4.22 billion$4.99 billion
Beta0.561.711.26N/A0.31
Average Volume658,448231,668375,918580,587767,872
Sales & Book Value
Annual Revenue$988.48 million$82.05 million$1.52 billionN/A$362.30 million
Price / Sales2.6755.323.95N/A13.28
Cashflow$2.30 per shareN/A$4.44 per shareN/AN/A
Price / Cash22.59N/A16.00N/AN/A
Book Value$11.67 per share$5.81 per share$16.50 per shareN/A$3.30 per share
Price / Book4.4628.714.30N/A23.28
Profitability
Net Income$76.53 million$-33,240,000.00$50.20 millionN/A$-24,750,000.00
EPS$3.31($1.40)$2.74N/A($0.22)
Trailing P/E Ratio25.12N/A105.930.00N/A
Forward P/E Ratio14.81N/A24.47N/AN/A
P/E Growth5.17N/A1.97N/AN/A
Net Margins11.76%-61.07%4.10%N/A-11.10%
Return on Equity (ROE)22.85%-32.23%14.26%N/A-10.98%
Return on Assets (ROA)10.40%-26.42%5.77%N/A-5.59%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.44%0.11%1.08%N/A0.61%
Current Ratio2.25%14.67%4.52%13.92%5.61%
Quick Ratio1.34%14.18%3.31%13.42%4.94%
Ownership Information
Institutional Ownership Percentage96.22%96.30%85.71%17.77%88.60%
Insider Ownership Percentage1.63%6.60%4.30%N/A6.00%
Miscellaneous
Employees3,0043413,7004561,500
Shares Outstanding50.82 million27.21 million84.55 million49.58 million62.64 million
Next Earnings Date5/13/2021 (Confirmed)8/3/2021 (Estimated)8/9/2021 (Estimated)8/10/2021 (Estimated)7/29/2021 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable
SourceHeadline
Tandem Diabetes Care (NASDAQ:TNDM) Issues FY 2021 Earnings GuidanceTandem Diabetes Care (NASDAQ:TNDM) Issues FY 2021 Earnings Guidance
americanbankingnews.com - May 12 at 11:06 AM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $102.00Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $102.00
marketbeat.com - May 12 at 9:44 AM
Tandem Diabetes Care (NASDAQ:TNDM) Given New $102.00 Price Target at SVB LeerinkTandem Diabetes Care (NASDAQ:TNDM) Given New $102.00 Price Target at SVB Leerink
americanbankingnews.com - May 12 at 9:14 AM
Robert W. Baird Stick to Their Hold Rating for Tandem Diabetes CareRobert W. Baird Stick to Their Hold Rating for Tandem Diabetes Care
investing.com - May 9 at 8:39 AM
Analysts Are Updating Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Estimates After Its First-Quarter ResultsAnalysts Are Updating Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Estimates After Its First-Quarter Results
nasdaq.com - May 8 at 2:23 PM
Tandem Diabetes Care (NASDAQ:TNDM) versus Inovio Pharmaceuticals (NASDAQ:INO) Financial ReviewTandem Diabetes Care (NASDAQ:TNDM) versus Inovio Pharmaceuticals (NASDAQ:INO) Financial Review
americanbankingnews.com - May 8 at 11:50 AM
 Analysts Expect Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Announce Quarterly Sales of $138.33 Million Analysts Expect Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Announce Quarterly Sales of $138.33 Million
americanbankingnews.com - May 8 at 2:02 AM
Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q1 2021 Results - Earnings Call TranscriptTandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 7 at 1:46 PM
-$0.09 EPS Expected for Tandem Diabetes Care, Inc. (NASDAQ:TNDM) This Quarter-$0.09 EPS Expected for Tandem Diabetes Care, Inc. (NASDAQ:TNDM) This Quarter
americanbankingnews.com - May 6 at 11:46 PM
Tandem Diabetes Care (NASDAQ:TNDM) Announces Quarterly  Earnings Results, Beats Expectations By $0.08 EPSTandem Diabetes Care (NASDAQ:TNDM) Announces Quarterly Earnings Results, Beats Expectations By $0.08 EPS
americanbankingnews.com - May 6 at 4:28 PM
SVB Leerink Raises Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $102.00SVB Leerink Raises Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $102.00
americanbankingnews.com - May 6 at 10:13 AM
Tandem Diabetes Care Inc (TNDM) Q1 2021 Earnings Call TranscriptTandem Diabetes Care Inc (TNDM) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 6 at 2:36 AM
Tandem Diabetes Care (NASDAQ:TNDM) Releases FY 2021 Earnings GuidanceTandem Diabetes Care (NASDAQ:TNDM) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 5 at 10:14 PM
Tandem Diabetes Care rises after hours on Street-beating Q1, raised guidanceTandem Diabetes Care rises after hours on Street-beating Q1, raised guidance
drugdeliverybusiness.com - May 5 at 9:32 PM
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue EstimatesTandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 5 at 9:32 PM
Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales GuidanceTandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance
finance.yahoo.com - May 5 at 4:32 PM
An Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests Its 26% UndervaluedAn Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests It's 26% Undervalued
finance.yahoo.com - May 4 at 7:07 PM
Custom Pre-earnings Bullish Diagonal Trigger in Tandem Diabetes Care IncCustom Pre-earnings Bullish Diagonal Trigger in Tandem Diabetes Care Inc
cmlviz.com - May 2 at 1:48 PM
Tandem Diabetes Care, Inc. (TNDM) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseTandem Diabetes Care, Inc. (TNDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - April 28 at 6:20 PM
Technical Short Put Spread Fade the Dip Trade and Trigger in Tandem Diabetes Care IncTechnical Short Put Spread Fade the Dip Trade and Trigger in Tandem Diabetes Care Inc
cmlviz.com - April 24 at 12:04 AM
Is TNDM Stock A Buy or Sell?Is TNDM Stock A Buy or Sell?
finance.yahoo.com - April 20 at 6:32 PM
-$0.15 EPS Expected for Tandem Diabetes Care, Inc. (NASDAQ:TNDM) This Quarter-$0.15 EPS Expected for Tandem Diabetes Care, Inc. (NASDAQ:TNDM) This Quarter
americanbankingnews.com - April 19 at 5:14 PM
Tandem Diabetes Care Inc (TNDM)Tandem Diabetes Care Inc (TNDM)
investing.com - April 18 at 6:39 PM
Tandem Diabetes Care Stock Gives Every Indication Of Being Modestly UndervaluedTandem Diabetes Care Stock Gives Every Indication Of Being Modestly Undervalued
gurufocus.com - April 17 at 11:15 AM
CeQur Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up of Automated Manufacturing for CeQur Simplicity Wearable Insulin-Delivery DeviceCeQur Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up of Automated Manufacturing for CeQur Simplicity Wearable Insulin-Delivery Device
finance.yahoo.com - April 13 at 8:27 AM
Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021
finance.yahoo.com - April 6 at 6:09 PM
DateCompanyBrokerageAction
4/26/2021HaemoneticsBarrington ResearchLower Price Target
4/26/2021HaemoneticsNeedham & Company LLCLower Price Target
4/26/2021HaemoneticsMorgan StanleyReiterated Rating
4/19/2021HaemoneticsCJS SecuritiesDowngrade
2/12/2021HaemoneticsRaymond JamesBoost Price Target
1/21/2021HaemoneticsJMP SecuritiesBoost Price Target
5/5/2021Inspire Medical SystemsLake Street CapitalBoost Price Target
5/5/2021Inspire Medical SystemsPiper SandlerBoost Price Target
4/25/2021Inspire Medical SystemsRobert W. BairdReiterated Rating
3/2/2021Inspire Medical SystemsSVB LeerinkBoost Price Target
1/4/2021Inspire Medical SystemsBank of AmericaDowngrade
12/15/2020Inspire Medical SystemsThe Goldman Sachs GroupDowngrade
11/3/2020Inspire Medical SystemsWells Fargo & CompanyBoost Price Target
11/3/2020Inspire Medical SystemsOppenheimerUpgrade
9/22/2020Inspire Medical SystemsJPMorgan Chase & Co.Initiated Coverage
8/21/2020Inspire Medical SystemsStifel NicolausBoost Price Target
4/29/2021Integra LifeSciencesCitigroupBoost Price Target
2/25/2021Integra LifeSciencesCredit Suisse GroupBoost Price Target
1/19/2021Integra LifeSciencesBTIG ResearchBoost Price Target
1/6/2021Integra LifeSciencesTruist FinancialBoost Price Target
8/11/2020Integra LifeSciencesUBS GroupBoost Price Target
5/12/2021Inari MedicalCanaccord GenuityBoost Price Target
7/31/2020Tandem Diabetes CareCraig HallumBoost Price Target
7/31/2020Tandem Diabetes CareGuggenheimUpgrade
7/7/2020Tandem Diabetes CareCowenBoost Price Target
(Data available from 5/13/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]tbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.